Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010–2019
Authors' conclusion
Our results may provide a better understanding of RA and its care in France.
Study context
- Population
- Patients identified with rheumatoid arthritis (RA) by ICD-10 codes (M05 and M06, except M06.1), France, 2010–2019318,243 followed in 2019
- Participants
- 385,919 patients
- Exposure
- Women vs Men
- Outcome
- Prevalence of RA in France
- Follow-up
- 2019
Methodological detailsnationwide, French National Health Data System (SNDS)
- Nationwide
- French National Health Data System (SNDS)
Main finding
As reported in the abstract
Overall crude prevalence of RA
- Overall crude prevalence rate
- 0.47%
Observational data: associations, not effects.
Further findings
Crude annual mortality rate
- Crude annual mortality rate
- 3.1%
Overall standardised mortality ratio (SMR) vs French general population (decreased over time) · 2019
- SMR
- 1.21
Cause-specific SMR
- Cardiovascular, SMR
- 1.40 (95% CI 1.36-1.43)
- Respiratory system, SMR
- 1.80 (95% CI 1.73-1.87)
- Digestive system, SMR
- 1.73 (95% CI 1.59-1.88)
- Urogenital system, SMR
- 1.73 (95% CI 1.59-1.88)
- Infections, SMR
- 1.91 (95% CI 1.76-2.06)
- No excess mortality due to tumours
Treatment prevalence · 2019
- csDMARD (n=133,477)
- 41.9%
- b/tsDMARD (n=59,409)
- 18.7%
Original publication
Prevalence, mortality, and treatment of patients with rheumatoid arthritis: A cohort study of the French National Health Data System, 2010–2019. Joint Bone Spine. Published 13 September 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →